Phase I trial improvement: A question of patient selection, trial design, or both? Editorial Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Clinical Trials, Phase I as Topic
  • Nomograms

publication date

  • February 20, 2014

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2013.53.6896

PubMed ID

  • 24419111

Additional Document Info

start page

  • 489

end page

  • 90

volume

  • 32

number

  • 6